1. Poly(α-hydroxy acid)-Based Nanoparticles for Drug/Gene Delivery for Cancer Therapy
   Narsireddy Amreddy et al, 2019, Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics CrossRef
2. Nanocarriers-Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead
   Ankit Sahoo et al, 2022, Hormone Related Cancer Mechanistic and Nanomedicines CrossRef
3. Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer
   Farhadul Islam et al, 2021, Cancer Medicine CrossRef
4. Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy
   Sergio Rey et al, 2017, Trends in Cancer CrossRef
5. Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival
   Zhenyu Xu et al, 2019, Scientific Reports CrossRef
6. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
   Sepideh Mirzaei et al, 2021, Cells CrossRef
7. Nanoformulations for Pharmacological siRNA Delivery in Cancer
   Byunghee Yoo et al, 2017, Design and Applications of Nanoparticles in Biomedical Imaging CrossRef
8. Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
   Eun-Jeong Won et al, 2022, Pharmaceutics CrossRef
9. EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial–mesenchymal transition
   Qiang Zhen et al, 2021, Strahlentherapie und Onkologie CrossRef
10. Nanoparticles Mediated circROBO1 Silencing to Inhibit Hepatocellular Carcinoma Progression by Modulating miR-130a-5p/CCNT2 Axis
    Hongyu Meng et al, 2023, International Journal of Nanomedicine CrossRef
11. Molecular targeting of hypoxia in radiotherapy
    Sergio Rey et al, 2017, Advanced Drug Delivery Reviews CrossRef
12. Nonviral siRNA delivery systems for pancreatic cancer therapy
    Shahin Aghamiri et al, 2021, Biotechnology and Bioengineering CrossRef
13. HCMV-miR-US33-5p promotes apoptosis of aortic vascular smooth muscle cells by targeting EPAS1/SLC3A2 pathway
    Jian Dong et al, 2022, Cellular & Molecular Biology Letters CrossRef
14. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer
    Qi Zhang et al, 2017, Molecular Cancer CrossRef
15. Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications
    Ivana Jarak et al, 2020, European Journal of Medicinal Chemistry CrossRef
16. RNAi-Based Approaches for Pancreatic Cancer Therapy
    Min Ju Kim et al, 2021, Pharmaceutics CrossRef
17. Formulation and Characterization of Doxycycline-Loaded Polymeric Nanoparticles for Testing Antitumor/Antiangiogenic Action in Experimental Colon Cancer in Mice
    Reem Alshaman et al, 2022, Nanomaterials CrossRef
18. MicroRNA‐383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain‐containing protein 1
    Hongjing Ma et al, 2016, Cell Biochemistry and Function CrossRef
19. Molecular Deregulation of EPAS1 in the Pathogenesis of Esophageal Squamous Cell Carcinoma
    Farhadul Islam et al, 2020, Frontiers in Oncology CrossRef
20. Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs
    John Kokkinos et al, 2020, Biomaterials CrossRef
21. Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
    Xi Hu et al, 2021, Advanced Science CrossRef